Back
Summit Therapeutics Stock Price Chart
Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Buy
62
SMMT
Summit Therapeutics
Last Price:
$25.84
Seasonality Move:
6.46%
7 Day Trial
ALL ACCESS PASS
$
7
Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.24 | Buy |
| 20-day SMA: | 24.61 | Buy |
| 50-day SMA: | 22.89 | Buy |
| 200-day SMA: | 19.82 | Buy |
| 8-day EMA: | 24.73 | Buy |
| 20-day EMA: | 24.57 | Buy |
| 50-day EMA: | 23.4 | Buy |
| 200-day EMA: | 18.95 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 54.39 | Buy |
| Chaikin Money Flow: | 105543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.47 - 28.67) | Buy |
| Bollinger Bands (100): | (18.09 - 24.77) | Buy |
Summit Therapeutics Technical Analysis
| May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 25.77 while SMMT 8-day simple moving average is 24.24, which is a Buy signal.
-
The stock price of SMMT is 25.77 while Summit Therapeutics 20-day SMA is 24.61, which makes it a Buy.
-
Summit Therapeutics 50-day simple moving average is 22.89 while SMMT share price is 25.77, making it a Buy technically.
-
SMMT stock price is 25.77 and Summit Therapeutics 200-day simple moving average is 19.82, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
62
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a BuyThe current Summit Therapeutics [SMMT] share price is $25.77. The Score for SMMT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
19.1B
Price in USD:
25.77
Share Volume:
2.9M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
2.10
Buy
62
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 25.77 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 25.77 while SMMT 8-day exponential moving average is 24.73, which is a Buy signal.
-
The stock price of SMMT is 25.77 while Summit Therapeutics 20-day EMA is 24.57, which makes it a Buy.
-
Summit Therapeutics 50-day exponential moving average is 23.40 while SMMT share price is 25.77, making it a Buy technically.
-
SMMT stock price is 25.77 and Summit Therapeutics 200-day simple moving average is 18.95, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Summit Therapeutics is a Buy
-
Summit Therapeutics Relative Strength Index (RSI) is 54.39, which suggest Summit Therapeutics is overbought
-
The Bollinger Bands (25) for Summit Therapeutics is (22.47 - 28.67), which suggest Summit Therapeutics is a Buy
-
The Bollinger Bands (100) for Summit Therapeutics is (18.09 - 24.77), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.